HP
TMO icon

HealthInvest Partners’s Thermo Fisher Scientific TMO Stock Holding History

HealthInvest Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
27,859
+4,873
+21% +$2.34M 3.76% 6
2026
Q1 		$14.4M Sell
22,986
-6,929
-23% -$3.76M 4.67% 3
2025
Q4 		$17.3M Buy
29,915
+2,768
+10% +$1.57M 5.53% 4
2025
Q3 		$1.4M Buy
27,147
+2,881
+12% +$1.34M 5.18% 5
2025
Q2 		$9.84M Buy
24,266
+1,409
+6% +$589K 4.21% 9
2025
Q1 		$11.4M Sell
22,857
-2,039
-8% -$1.1M 5.02% 6
2024
Q4 		$12.9M Buy
24,896
+2,884
+13% +$1.59M 6.13% 5
2024
Q3 		$13.6M Buy
22,012
+2,554
+13% +$1.51M 6.4% 4
2024
Q2 		$10.8M Buy
19,458
+4,272
+28% +$2.45M 6.56% 4
2024
Q1 		$8.83M Buy
15,186
+3,771
+33% +$2.12M 5.37% 4
2023
Q4 		$6.06M Buy
+11,415
New +$5.53M 4.74% 6
2022
Q4 		$121K Buy
+220
New +$117K 0.23% 15

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HealthInvest Partners's TMO Position: Q2 2026 in Review

HealthInvest Partners increased its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, buying an estimated $2.34M and bringing the position to 27,859 shares worth $14M. The position accounts for 3.76% of the portfolio, ranked #6.

HealthInvest Partners first reported a position in TMO in Q4 2022 and has held it in 12 quarters since. The position peaked at $17.3M in Q4 2025. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HealthInvest Partners held 27,859 shares of Thermo Fisher Scientific worth $14M as of Q2 2026.
  • HealthInvest Partners bought 4,873 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.34M.
  • Thermo Fisher Scientific made up 3.76% of HealthInvest Partners's portfolio in Q2 2026, its #6 holding.
  • HealthInvest Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 12 quarters since.
  • HealthInvest Partners's Thermo Fisher Scientific position peaked at $17.3M in Q4 2025.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.